Apixaban and dalteparin in active malignancy‐associated venous thromboembolism: The ADAM VTE trial

Robert D. McBane, Waldemar E. Wysokiński, Jennifer Le‐Rademacher, +14

Journal of Thrombosis and Haemostasis

ThrombosisVenous ThrombosisAdam Vte TrialHematologyPharmacology +4

Spontaneous coronary artery dissection and its association with heritable connective tissue disorders

Stanislav Henkin, Sara Negrotto, Marysia S. Tweet, +5

Heart

Apixaban and dalteparin in active malignancy associated venous thromboembolism

Charles L. Loprinzi, Aneel A. Ashrani, Juliana Perez Botero, +6

Thrombosis and Haemostasis

Impact of the Learning Curve for Endoscopic Vein Harvest on Conduit Quality and Early Graft Patency

Pranjal Desai, Soroosh Kiani, Nannan Thiruvanthan, +6

The Annals of Thoracic Surgery

Vascular SurgeryEarly Graft PatencyLearning CurveSurgeryVascular Access +6

Improving nurse-physician teamwork through interprofessional bedside rounding

John T. Ratelle, Stanislav Henkin, Tony Y. Chon, +3

Journal of Multidisciplinary Healthcare

Ovarian Vein Thrombosis

Charles J. Lenz, Waldemar E. Wysokiński, Stanislav Henkin, +8

Obstetrics and Gynecology

Segmental Arterial Mediolysis: Abdominal Imaging of and Disease Course in 111 Patients

Sailen G. Naidu, Christine O. Menias, Rahmi Öklü, +6

American Journal of Roentgenology

Apixaban, Dalteparin, in Active Cancer Associated Venous Thromboembolism, the ADAM VTE Trial

Robert D. McBane, Waldemar E. Wysokiński, Jennifer Le‐Rademacher, +11

Blood

Extending venous thromboembolism secondary prevention with apixaban in cancer patients. The EVE trial

Robert D. McBane, Charles L. Loprinzi, Tyler Zemla, +17

Journal of Thrombosis and Haemostasis

ThrombosisVenous DiseaseOncologyVenous ThrombosisClinical Trials +6

Impact of a History of Hypertension in Pregnancy on Later Diagnosis of Atrial Fibrillation

Dawn C. Scantlebury, Andrea G. Kattah, Tracey L. Weissgerber, +10

Journal of the American Heart Association